Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The investigators do the clinical trial (patients with metastatic colorectal cancer treated
with donafenib after failure of standard therapy) to assess safety and efficacy of donafenib
in patients with metastatic colorectal cancer, progressing after all approved standard
therapies.